Valuation: Healthconn Corp.

Market Cap 891M 27.96M 24.51M 22.6M 21.15M 39.67M 2.64B 40.49M 272M 105M 1.3B 105M 103M 4.52B P/E 2024
43.8x
P/E 2025 108x
Enterprise Value 772M 24.22M 21.23M 19.57M 18.32M 34.36M 2.28B 35.07M 235M 91.03M 1.13B 90.93M 88.95M 3.91B EV / Sales 2024
0.41x
EV / Sales 2025 0.7x
Free-Float
58.01%
Yield 2024
3.81%
Yield 2025 0.74%
1 week-2.24%
Current month-1.75%
1 month-3.68%
3 months-0.76%
6 months-1.01%
Current year-2.00%
1 week 18.9
Extreme 18.9
20.4
1 month 18.4
Extreme 18.4
21.55
Current year 18.4
Extreme 18.4
24.4
1 year 18.4
Extreme 18.4
26.15
3 years 16.9
Extreme 16.9
38.75
5 years 16.9
Extreme 16.9
57.2
10 years 16.9
Extreme 16.9
247.02
Manager TitleAgeSince
Chief Executive Officer - 2023-12-20
Director of Finance/CFO - 2018-12-20
Comptroller/Controller/Auditor - 2021-03-21
Director TitleAgeSince
Director/Board Member - 2017-12-26
Director/Board Member - 2020-06-21
Director/Board Member - 2022-06-16
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.24%-21.56%-46.02% 27.96M
+2.26%+1.26%-24.68%-31.17% 183M
-1.82%-4.98%-34.73%-54.67% 181M
-0.79%-1.42%-38.02%+9.82% 52.65M
Average -0.09%-1.45%-29.75%-30.51% 111.15M
Weighted average by Cap. +0.09%-0.96%-30.16%-36.84%

Financials

2024 2025
Net sales 1.25B 39.32M 34.48M 31.78M 29.75M 55.79M 3.71B 56.95M 382M 148M 1.83B 148M 144M 6.36B 1.13B 35.48M 31.11M 28.68M 26.85M 50.34M 3.35B 51.39M 345M 133M 1.65B 133M 130M 5.74B
Net income 19.23M 603K 529K 488K 456K 856K 56.9M 874K 5.86M 2.27M 28.12M 2.27M 2.22M 97.52M 8.39M 263K 231K 213K 199K 374K 24.84M 381K 2.56M 990K 12.28M 989K 967K 42.57M
Net Debt -317M -9.96M -8.73M -8.05M -7.54M -14.13M -940M -14.42M -96.75M -37.44M -464M -37.4M -36.58M -1.61B -119M -3.74M -3.28M -3.02M -2.83M -5.31M -353M -5.42M -36.33M -14.06M -174M -14.05M -13.74M -605M
Logo Healthconn Corp.
HEALTHCONN CORP. is a Taiwan-based Company mainly engaged in the provision of disease prevention and treatment services. The Company is engaged in the provision of precisely prevent medical integration services, molecular biology testing programs and accurate diagnostic testing services. The precisely prevent medical integration services include precisely prevention, disease management and health promotion services. The molecular bioassay services include food safety testing and functional medical testing services. The accurate diagnostic testing services include molecular testing and clinical microbiological testing services, as well as the development and operation of medical health institutions. The Company is also engaged in the medical equipment sale business. The Company operates in the Taiwan market as well as in the mainland China market.
Employees
205
Date Price Change Volume
26-06-26 NT$19.65 0.00% 2,036
26-06-25 NT$19.65 +1.03% 35,486
26-06-24 NT$19.45 -1.77% 19,327
26-06-23 NT$19.80 -1.49% 48,130
  1. Stock Market
  2. Stocks
  3. 6665 Stock